BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28523822)

  • 1. Development of a novel flow cytometric immunobead array to quantify VWF: Ag and VWF: GPIbR and its application in acute myocardial infarction.
    Yan B; Xu M; Zhao Y; Guo H; Xia L; Ruan C; Zhao Y
    Eur J Haematol; 2017 Sep; 99(3):207-215. PubMed ID: 28523822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of Flow Cytometric Immunobead Array for Detecting Plasma Von Willebrand Factor Activity and Its Clinical Application in the Prognosis of Ischemic Stroke].
    Yan B; He Y; Lu SQ; Xu MQ; Wang Q; Zhao YM; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):208-214. PubMed ID: 30738472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment and Clinical Application of Flow Cytometric Immunobead Array in Detecting Plasma von Willebrand Factor Antigen].
    Yan B; He Y; Lu SQ; Qu L; Xu MQ; Wang Q; Zhao YM; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):235-241. PubMed ID: 32027283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
    Vangenechten I; Mayger K; Smejkal P; Zapletal O; Michiels JJ; Moore GW; Gadisseur A
    J Thromb Haemost; 2018 Jul; 16(7):1268-1277. PubMed ID: 29742318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
    Patzke J; Favaloro EJ
    Methods Mol Biol; 2017; 1646():453-460. PubMed ID: 28804847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP
    Seidizadeh O; Peyvandi F
    Methods Mol Biol; 2023; 2663():669-677. PubMed ID: 37204744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease.
    Stufano F; Baronciani L; Bucciarelli P; Boscarino M; Colpani P; Pagliari MT; Peyvandi F
    Haemophilia; 2020 Mar; 26(2):298-305. PubMed ID: 32107842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.
    Favaloro EJ; Oliver S; Mohammed S; Vong R
    Haemophilia; 2020 May; 26(3):503-512. PubMed ID: 32159272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size.
    Liang Q; Parker ET; Dean G; Karpen MS; Wu Y; Wang X; Di Paola J; Maier CL; Meeks SL; Lollar P; Sidonio RF; Li R
    J Thromb Haemost; 2024 Jul; 22(7):2052-2058. PubMed ID: 38704122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
    Federici AB; Canciani MT; Forza I; Mannucci PM; Marchese P; Ware J; Ruggeri ZM
    Haematologica; 2004 Jan; 89(1):77-85. PubMed ID: 14754609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.
    Zhai J; Ding M; Yang T; Zuo B; Weng Z; Zhao Y; He J; Wu Q; Ruan C; He Y
    J Transl Med; 2017 Oct; 15(1):214. PubMed ID: 29061180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA.
    Vanhoorelbeke K; Pareyn I; Schlammadinger A; Vauterin S; Hoylaerts MF; Arnout J; Deckmyn H
    Thromb Haemost; 2005 Jan; 93(1):165-71. PubMed ID: 15630508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.